Medigap Premiums Spike Up to 45% as Medicare Advantage Payments Rise Only 2.7%

Why It Matters

The twin pressures of soaring Medigap premiums and modest Medicare Advantage payment increases reshape retirement budgeting for millions of Americans. Higher out‑of‑pocket costs force retirees to allocate a larger share of fixed incomes to health care, potentially crowding out other essential expenses such as housing, food, and long‑term care. Moreover, the divergent trends highlight regulatory gaps: while CMS can adjust MA payments, there is limited oversight of private Medigap rate setting, leaving consumers vulnerable to abrupt price shocks. Understanding these dynamics is critical for financial advisors, insurers, and policymakers. Advisors must reassess cost‑projection models for retirement plans, insurers may need to balance premium adequacy with market competitiveness, and legislators could consider stronger consumer‑protection statutes to curb excessive Medigap hikes. The outcome will influence not only individual financial security but also the broader health‑care financing ecosystem as the baby‑boomer cohort ages.

Key Takeaways

• Chubb Medigap customers saw a 45% premium jump in August 2023, the largest immediate increase reported.
• Early 2026 filings show Plan G Medigap rates rising 12%‑26% across major carriers.
• CMS raised Medicare Advantage payment rates to about 2.7% for 2026, up from sub‑1% projections.
• Average Plan G premium was $164/month in 2023; Alaska rates now top $190/month after a 12% rise.
• Experts warn that higher Medigap costs may push retirees toward MA plans that could trim supplemental benefits.

Pulse Analysis

The current premium environment signals a tipping point in the supplemental Medicare market. Historically, Medigap rates have risen modestly—typically 3%‑5% annually—reflecting predictable cost inflation. The recent wave of double‑digit hikes, culminating in a 45% surge for a single carrier, suggests that insurers are recalibrating risk pools after a period of unusually low claim ratios. This recalibration is likely driven by a confluence of factors: an aging beneficiary base, increased utilization of high‑cost services, and the migration of healthier seniors into Medicare Advantage plans, which leaves a sicker residual pool in the Medigap market.

From a strategic standpoint, insurers may be leveraging the CMS payment increase as a buffer, but the 2.7% uplift is insufficient to offset the higher claim costs that prompted the Medigap rate spikes. As a result, we can expect a continued divergence: Medigap premiums will keep climbing, while MA plans may either maintain current premium levels or modestly increase them, relying on supplemental benefits as a differentiator. Financial planners should therefore model retirement cash flows with a higher health‑care cost baseline and advise clients to lock in Medigap coverage during the guaranteed‑issue window to avoid medical underwriting penalties.

Regulators could intervene by mandating greater rate‑review transparency or capping annual increases, similar to policies in a handful of states that already limit Medigap hikes. Until such measures materialize, the market will likely see heightened competition among brokers and insurers to offer hybrid solutions—combining lower‑cost MA plans with targeted supplemental riders—to retain price‑sensitive retirees. The next enrollment cycle will be a litmus test for how effectively the industry can balance cost pressures with consumer protection.